Laboratory mice are well known to be highly susceptible to virulent strains of Yersinia pestis in experimental models of bubonic plague. We have found that Mus spretus-derived SEG/Pas (SEG) mice are exceptionally resistant to virulent CO92 and 6/69 wild type strains. Upon subcutaneous injection of 10 2 colony-forming units (CFU), 90% of females and 68% of males survived, compared with only an 8% survival rate for both male and female C57BL/6 mice. Furthermore, half of the SEG mice survived a challenge of up to 10 7 CFU. The time required for mortality was similar between B6 and SEG, suggesting that survival is dependent on early rather than late processes. The analysis of 322 backcross mice identified three significant quantitative trait loci (QTLs) on chromosomes 3, 4 and 6, with dominant SEG protective alleles. Each QTL increased the survival rate by approximately 20%. The three QTLs function additively, thereby accounting for 67% of the difference between the parental phenotypes. Mice heterozygous for the three QTLs were just as resistant as SEG mice to Y. pestis challenge. The SEG strain therefore offers an invaluable opportunity to unravel mechanisms and underlying genetic factors of resistance against Y. pestis infection.
Introduction
Yersinia pestis, a Gram-negative bacterium, is the etiological agent of human bubonic and pneumonic plague. Starting from the bite of a Y. pestis-hosting flea, bubonic plague is characterized by rapid multiplication of the bacteria in the bite site-draining lymph node and is fatal in at least 50% of untreated cases, owing to sepsis and multiple organ failure. Pneumonic plague results from the colonization of the lung by bacteria via infectious respiratory droplets. It is the most contagious and deadliest manifestation of the disease, with a 100% mortality rate in the absence of effective antibiotherapy. 1 Although the current worldwide incidence of plague is low compared with historical records, the steady increase in reported human cases during the past 15 years coupled with its re-emergence in areas otherwise declared plague-free for several decades has led to classify plague as a re-emerging disease, 2 a threat exacerbated by the recent identification of a antibiotic resistant strain. 3 Moreover, rapid disease progression with a high mortality rate, the absence of efficient, safe vaccines and the possibility of aerosol dispersion makes Y. pestis a potential major agent for bioterrorism. 4 Historical records of plague pandemics indicate that a fraction of the individuals who developed bubonic plague were able to survive, suggesting that genetic factors of the mammalian host may also influence the outcome of the infection. It is likely that plague, which killed one third of the European population during the 1347-1351 Black Death, has exerted a rapid but strong selective pressure on the human genome. In animals, not all species are equally susceptible to plague. Although most rodents, cats, camels and monkeys are susceptible, dogs and cows are usually resistant to Y. pestis. 5 These differences in susceptibility could help understand how Y. pestis overcomes the human immune system, identify which individuals are at risk, and form a basis for the development of new strategies for therapeutic and vaccine intervention.
Using a forward genetic approach to decipher the genetic control of natural variation in host resistance to viral, parasitic or bacterial infections has already demonstrated its power to unravel the molecular mechanisms engaged in host-microbes interactions. 6 The strength of this approach resides in its ability to identify previously unknown mechanisms and characterize their hierarchy, interactions and individual contributions to the pathogenesis of infectious agents. However, its power remains very limited in humans, in particular, because Y. pestis-infected patients undergo antibiotic treatment, thereby masking their intrinsic ability to control bacterial burden, the associated tissue damage and systemic inflammatory processes.
The availability of animal models relevant to human infectious diseases makes the identification of susceptibility genes possible under controlled experimental conditions in which strain, virulence, dose and route of Y. pestis inoculation are standardized. Among rodents, mice are of special interest as they are naturally susceptible to plague 7 and mouse offers powerful genetics tools to identify susceptibility and resistance genes even when the trait is under complex genetic control. Genetic and phenotypic dissection, which is critical in untangling complex sequences of events with many participating tissues and cell types, can be achieved using congenic strains, in which specific genomic regions harboring a small group of genes are transferred between susceptible and resistant backgrounds.
Differences in susceptibility to Y. pestis have been recently reported between laboratory inbred strains of mice, 8 including the mapping of two resistance alleles, close to the interleukin-10 gene (chromosome 1) 9 and histocompatibility complex (chromosome 17). 10 These results were obtained upon intravenous injection of the Y. pestis mutant strain KIM5, which lacks the chromosomal pgm locus. As this strain is highly attenuated, it has to be given intravenously to cause a lethal infection. Although direct penetration of Y. pestis into the blood stream may occur during a flea bite, it is a very uncommon mode of transmission. Furthermore, the relevance of these results to natural infection in animals and humans is limited, as the same inbred strains of mice are susceptible to virulent Y. pestis strains. 8 All classical laboratory strains (such as C57BL/6 (B6)) are susceptible to subcutaneous (s.c.) injection of the fully virulent Y. pestis strain C092, an experimental setting designed to mimic many features of natural exposure.
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In this study, we report that the SEG/Pas (SEG) inbred strain, which was established from Mus spretus progenitors, exhibits a high level of resistance under the same conditions. The genetic analysis of a large backcross cohort between SEG and B6 identified three dominant, additively acting loci that account for most of the difference in susceptibility observed between the two strains.
Results

SEG mice resist virulent Y. pestis
Several inbred strains of mice were tested for their ability to survive an infection with the fully virulent Y. pestis strain CO92. Inoculation by s.c. injection of 100 colonyforming units (CFU) in the ventral region was lethal within 4-12 days for almost all the B6 mice. This dose was used to challenge females of three additional laboratory inbred strains (FVB/N, BALB/cByJ and SJL/J), as well as one Mus musculus castaneus-derived strain (CAST/Ei) and the M. spretus-derived SEG strain (Figure 1 ). B6 and SEG mice were tested in several experiments and as the results were consistent throughout, the data were pooled.
SEG female mice were exceptionally resistant (90% survival; 62/69) compared with FVB (23% survival; 5/22) or less in other strains. Only 6.3% (7/111) of B6 mice survived the infection (Figure 1) . Interestingly, the few SEG mice that did succumb to the infection did so at the same average time point as B6 mice (Figure 2 ). SEG survivors developed symptoms characterized by a mild hypotonia and reduced activity between days 4 and 6 after inoculation, before recovering. SEG mice that were susceptible progressed towards marked depression and prostration and finally died. In B6 mice, death often occurred rapidly after the appearance of the first symptoms.
To further evaluate the level of resistance of SEG mice to the fully virulent CO92 strain, groups of females were inoculated subcutaneously with 10-fold dilutions ranging from 10 3 to 10 7 CFU of CO92. Remarkably, even the highest doses were unable to cause death in more than 50% of the mice (Supplementary Figure 1a) . The mortality time point of susceptible SEG mice varied across groups, but did not correlate with the number of bacteria inoculated. We therefore concluded that the SEG strain exhibits an exceptional level of resistance to s.c. inoculation with the fully virulent Y. pestis. Such a resistance has never been reported for any other mouse strain.
Female SEG mice are more resistant than males B6 males and females inoculated subcutaneously with 10 2 CFU of strain CO92 exhibited the same high level of susceptibility (Supplementary Figure 1b) . By contrast, SEG males were significantly less resistant (68.5% survival; 37/54) than females (89.9% survival; 62/69, Mus spretus mice resistant to virulent Yersinia pestis C Blanchet et al P ¼ 0.005). As the difference of susceptibility between SEG and B6 strains was higher in females than in males, further studies, including genetic mapping of quantitative trait loci (QTLs), were carried out with females.
The exceptional resistance of SEG mice to Y. pestis is not CO92 strain specific In order to assess whether the resistant phenotype of SEG mice was specific to Y. pestis strain CO92, we challenged B6 and SEG female mice with 100 CFU of another wild type virulent strain, denoted as strain 6/69. 12 Survival curves obtained with the two bacterial strains were similar (Supplementary Figure 2) , demonstrating that SEG mice resistance is not Y. pestis strain specific.
Multigenic control of resistance to Y. pestis in SEG mice When a group of (B6 Â SEG)F1 females (n ¼ 16) were challenged by s.c. inoculation of 10 2 CFU of CO92 strain, 75% (12/16) of them survived, a resistance level not significantly lower than that of SEG mice (P ¼ 0.21). This suggests a dominant mode of inheritance for SEGderived resistance alleles. An interspecific backcross was produced to characterize the genetic regions that account for the resistance of SEG mice. F1 females, born from the cross of B6 females and SEG males, were mated with B6 males to yield B6 Â (SEG Â B6)F1 backcross mice (BSB) progeny, out of which 322 females were challenged subcutaneously with 10 2 CFU of Y. pestis CO92. One hundred and ninety females survived the infection, giving a survival rate of 59%. This proportion was significantly lower than that of SEG mice (P ¼ 3.2 Â 10
À7
), but significantly higher (P ¼ 0.0015) than the 50% expected if resistance was inherited as a simple Mendelian trait. From these data, we conclude that resistance of SEG mice to Y. pestis is under the control of multiple genes, likely with SEG alleles acting in a dominant manner.
The mortality time point of susceptible BSB females was similar to that of B6 and SEG mice in both mean value and s.d. (Figure 2 ), suggesting that this cross did not segregate genes controlling this trait. In fact, we did not find any significant QTL controlling mortality time. The QTL search therefore focused on survival, analyzed as a binary trait.
Single nucleotide polymorphism genotyping was performed using 721 polymorphic markers covering the entire genome of BSB females. QTL analysis using R/qtl software, revealed the presence of three chromosomal regions significantly associated with survival on mouse chromosomes 3, 4 and 6 ( Figure 3) . In all cases, the LOD curve reached the 5% genome-wide significance threshold computed by data permutation. These loci were named Y. pestis resistance locus-1 (Yprl1), Yprl2 and Yprl3, respectively. Their putative location was taken as the position of the marker with the highest LOD score value. Yprl1, Yprl2 and Yprl3 were positioned at 116, 62 and 95 Mb on chromosomes 3, 4 and 6, respectively. Their 95% confidence intervals (CI) were 50, 84 and 81 Mb long, respectively ( Table 1) .
The individual effects of each QTL were assessed by comparison of survival curves of BSB females depending on their genotype at the peak single nucleotide polymorphism marker. The SEG allele at the Yprl1 locus was associated with a highly significant increase in resistance Table 1 ).
Interactions between pairs of loci were investigated by comparing survival rates of the four genotype combinations in two-locus effect plots. For example, the difference of survival between Yprl2 B/B and Yprl2 B/S mice was 21.1 % within the group of Yprl1 B/B mice, while it was 18.0% within the Yprl1 B/S mice (Supplementary Figure 3) . As these two values were not significantly different (P ¼ 0.97), we concluded that the effect of Yprl2 was independent of the genotype of the mice at the Yprl1 locus, and reciprocally. Similar observations were made with Yprl1-Yprl3 and Yprl2-Yprl3 pairs of QTLs, thus suggesting that the three QTLs add up their individual effects without epistasis.
We also searched for additional QTLs, which could have remained undetected using the one-QTL search, because of epistatic interactions. The 'scantwo' feature of R/qtl did not detect any additional locus significantly associated with survival.
Yprl1, 2 and 3 function additively to confer survival in BSB mice As the three QTLs appear to function independently of one another, we investigated the level of resistance of BSB mice for each of the eight possible genotype combinations at the three loci ( Figure 5 ). This analysis was made possible by the large size of the cross, which resulted in group sizes of at least 33 individuals. Groups were sorted by increasing proportion of SEG alleles at the three QTLs. The distribution of survival rates across groups was compared with that of B6 and SEG. Mice heterozygous for the SEG allele at the three QTLs show a level of resistance similar to that of SEG (82.7 and 89.9%, respectively). Conversely, mice homozygous for the B6 allele at the three QTLs had the lowest level of resistance (27.0%), but were significantly less susceptible than B6 mice (P ¼ 0.0017). The other groups of BSB mice showed intermediate levels of resistance and groups of mice heterozygous for only one QTL were globally more susceptible than those heterozygous for two QTLs (48.5 and 68.0% survival, respectively; P ¼ 0.0043). We draw four main conclusions from this analysis. First, SEG resistance alleles are dominant over B6 susceptibility allele. Second, the three QTLs function additively and together they account for 67% of the difference in survival to Y. pestis challenge between the two parental strains. Third, these QTLs provide BSB mice with the same level of resistance as parental SEG mice. Fourth, there remain undetected QTLs that contribute to significant resistance even in the absence of the three Yprl loci.
Discussion
Although plague is no longer a major threat to the human population, the recent re-emergence of the disease in several countries, 2 the isolation of antibiotic resistant strains 3 and the exceptional pathogenicity of Y. pestis fully justify studies aimed at unraveling the mechanisms by which this bacterium is able to induce so efficiently and rapidly a deadly infection of its host. The mouse is a relevant animal model to explore the pathophysiology of plague owing to the fact that it is a natural and susceptible host for Y. pestis. Most previous studies have explored the bubonic form of the disease, although a model for primary pneumonic plague has been recently described and investigated. 13 The majority of in vivo genetic studies previously published on mouse models have focused on the role of genetic determinant in Y. pestis on bacterial load and histological damages in different host tissues. 14, 15 However, two recent reports identified regions of the mouse genome associated with the variable susceptibility of classical inbred mouse strains to Y. pestis. The first study showed that the previously reported resistant phenotype of Il10 knockout mice was partially due to a closely linked resistance allele inherited from the 129/P2J genetic background of the embryonic stem cells used for gene targeting. 9 The second study described the resistant phenotype of the BALB/cJ strain, compared with susceptible BALB/c substrains and C57BL/6J. Using a combination of backcrossing and intercrossing, a QTL was mapped in the H2 region on proximal chromosome 17. 10 However, both studies were performed using the attenuated Y. pestis strain KIM5 which lacks the pgm locus, an important virulence factor. 16 This deletion requires that inoculation of Y. pestis be performed intravenously, a route that ensures rapid dissemination of the bacteria, but one that also bypasses several important processes, in particular those deployed in the skin and the draining lymph node.
In this study, we aimed to identify host genetic determinants of resistance to plague, under experimental conditions that more closely resemble natural infection, that is, using a wild type, fully virulent Y. pestis strain and a s.c. route of transmission. We took advantage of our collection of wild-derived strains maintained at the Institut Pasteur, Paris, France to explore mouse genetic diversity. This strategy has been previously successful in our hands, with the identification of Oas1b gene as a major determinant of resistance to West Nile virus. 17 Indeed, although almost all laboratory inbred strains are highly susceptible to this virus owing to a point mutation in the Oas1b gene, all wild-derived strains are highly resistant and carry a functional allele.
In the present study, all tested strains (including Mus m. castaneus CAST/EiJ) were found to be susceptible to plague, with the exception of the M. spretus-derived SEG strain, which exhibited remarkable resistance. Even inoculation of very high bacterial titers did not lead to mortality in more than 50% of the mice. One possible explanation for the high-dose resistance of SEG mice could be genetic heterogeneity in the breeding colony, with a mutation conferring complete resistance to high doses segregating in a low-dose resistant inbred genetic background. However, careful analysis of the pedigree of the SEG mice used in this experiment ruled out this possibility. Another explanation might be a dose-dependent stimulation of the SEG innate immune response, with an enhanced and unsaturated capacity to clear the bacteria.
We have identified for the first time a mouse strain that displays high level resistance to inoculation of fully virulent Y. pestis strains, opening a double perspective to better understand the interactions between this highly pathogenic bacterium and its host. First, having both highly resistant and very susceptible mouse strains is an invaluable resource to identify the mechanisms, especially during the early phases following Y. pestis inoculation, which are triggered or disengaged by Y. pestis and influence the outcome of host-pathogen interactions. Second, genes controlling this difference can be identified by QTL mapping in two generations, although interspecific crosses between M. spretus and laboratory strains invariably result in sterile F1 males, thereby preventing the production of F2 progeny. This forward genetic strategy has already been proven to be successful for the identification of key genes for the control of bacterial, viral or parasitic diseases. 6 An interspecific backcross using SEG and B6 as parental strains was therefore produced. We analyzed more than 300 females as we suspected that SEG resistance was not controlled by a single gene and that scoring the phenotype as a binary (death or survival) trait, resulting from a complex series of host-bacteria interactions, would result in reduced power of QTL detection. In fact, this large number of animals is required to identify a QTL controlling 20% difference in survival, with a 0.05 genome-wide significance threshold. We identified three significant QTLs, each of which was able, in the context of the segregating background of BSB mice, to confer a 20% increase in survival, from 48 to 68% on average. Moreover, pair wise analysis of QTL effects revealed an additive mode of action. Subsequently, the survival rate of BSB mice increased as a function of the SEG alleles present at the three QTLs and mice heterozygous at Yprl1, 2 and 3 displayed the same level of resistance as SEG mice ( Figure 5 ). However, as mice homozygous for the B6 allele at the three QTLs were significantly more resistant than B6 mice, there remain other resistance genes to be identified, which may be too numerous, or may have too weak effects to be detectable in a cross of this size.
Taken together, these data suggest a model for resistance to Y. pestis virulent strains in SEG mice ( Figure 6 ). The B6 strain has a very weak ability to resist Y. pestis, which results most frequently in rapid mortality. One or more yet unidentified loci increase the resistance to a level wherein approximately 30% of mice eventually survive the infection. The three Yprl loci mapped in our study significantly improve resistance to Y. pestis and together recapitulate the resistance of SEG mice. We cannot predict the contribution the three Yprl loci provide to resistance, in the absence of the unidentified loci. It is possible that these unknown loci have a critical role and create a genomic context favorable to the action of the Yprl loci, so that strains congenic for only one of any of the Yprl loci may not show a significant increase in survival rate compared with B6.
The survival curves of the mice that died of the infection showed exactly the same decrease over time, across the B6, SEG and BSB populations (Figure 2 ). This observation suggests that the disease course in the mice, which finally succumb to the Y. pestis challenge is very similar in these three different genetic backgrounds. Thus, the final outcome of infection would depend on events taking place during the first two or three days, before the first mice die. The Yprl1, 2 and 3 regions overlap several QTLs associated with susceptibility to other bacteria, to viruses or parasites (Supplementary Table 1 ). Regarding bacterial diseases, Tbs1 is involved in control of both body weight loss and survival time following challenge with virulent Mycobacterium tuberculosis, which are rather late phenotypes. Msts2 influences acute inflammatory reaction, which correlates with survival following Salmonella typhimurium s.c. injection. This QTL could be relevant to our phenotype and maps close to the Yprl3 peak location. Three other QTLs, associated with susceptibility to Chlamydia trachomatis and Salmonella enteritidis have been mapped at the boundaries of the Yprl CI and are hence, less attractive.
Although the CI of the Yprl1, 2 and 3 loci encompass large chromosomal segments (between 50 and 84 Mb), it is also possible to consider potential candidate genes in these regions that may, because of their known function in host immune or inflammatory responses, contribute to the observed phenotype. The Yprl1 CI contains the Pglyrp3 and Pglyrp4 genes, which are antimicrobial peptides secreted by skin, eyes, oral cavity and gastrointestinal tract in response to pathogen recognition. They have an important role against pathogenic bacteria such as Listeria monocytogenes and Staphylococcus aureus, but seem to be less efficient against Gram-negative bacteria. 18 Interleukin 6 receptor a chain (Il6ra) also maps to Yprl1. Interleukin-6 is a pleiotropic cytokine expressed by antigen presenting cells such as dendritic cells, macrophages and B cells but also by a variety of nonhematopoietic cells. 19 It acts synergistically with a number of growth factors and cytokines to sustain normal proliferation and maturation of macrophages, T and B cells. It has been shown to have a role in resistance to bacteria (such as Listeria monocytogenes 20 ) or viruses. 21 The main candidate in the Yprl2 region is the toll-like receptor 4 gene (Tlr4), located on the QTL peak. It is involved in the recognition of lipopolysaccharide (LPS), a major component of the outer membrane of Gram-negative bacteria. 22 Several mouse strains are hyporesponsive to LPS owing to Tlr4 mutations and show increased susceptibility to Gram-negative S. typhimurium, whereas transgenic mice possessing more than two extra copies of the gene survived longer and in a greater percentage to Salmonella infection. 23 Y. pestis also produces LPS, however the Tlr4 stimulating activity of its LPS-lipid A is reduced when the bacteria is at mammalian body temperature. 24 It would therefore be interesting to compare the Tlr4 responses of B6 and SEG mice after exposure to Y. pestis LPS. Other genes of interest in the Yprl2 region are 14 genes of the type I interferon and interferon receptor families, although studies have emphasized the role of type II gamma interferon in the control of Y. pestis multiplication in the host. 25, 26 Yprl3 overlaps several potential candidate genes. The nucleotide-binding oligomerization domain containing 1 (Nod1) gene is an intracellular pattern recognition receptor that mediates innate and acquired immunity by recognizing diaminopimelate-containing muropeptides from Gram-negative bacteria peptidoglycan, which activates the NF-kB pathway. 27 Nod1 deficiency results in increased susceptibility to various Gram-negative bacteria, including Helicobacter pylori, 28 Pseudomonas aeruginosa 29 and S. typhimurium. 30 The interleukin-17 (IL-17) pathway is another interesting lead. There are six IL-17 family members and five receptors. Specifically, IL-17RA and IL-17RC subunits of IL-17 receptor, which map to the Yprl3 interval (Supplementary Table 1) , interact with IL-17 and IL-17F to induce production of other proinflammatory cytokines, chemokines and growth factors, 31 leading to an accumulation of neutrophils at the sites of infection and inflammation. 32 In fact, several studies have reported that IL-17R deficiency results in significant delay in neutrophil recruitment and impaired host defense against bacteria including L. monocytogenes, 33 Bacillus subtilis 34 and Klebsiella pneumoniae. 35 Finally, Yprl3 also contains IL-23 receptor, which has been shown to regulate the function of specific IL-17-producing T-cells. 36 Future work will aim to narrow down the list of candidate genes by reducing the CI using congenic strains and by searching for variations in the primary sequence or expression level of specific genes. Whatever the genes involved, it is likely that the SEG resistance alleles are gain-of-function variants, owing to their dominant mode of inheritance.
The M. spretus species diverged from Mus musculus more than 1 million years ago. 37 The genetic divergence between them at the nucleotide level is estimated to be 1-1.5%, the same order of magnitude seen between human and chimpanzee. Our observation of the exceptional resistance of SEG mice to Y. pestis illustrates the usefulness of M. spretus-derived strains as a source of genetic and phenotypic polymorphism. 38 The fact that the differences in susceptibility to plague between B6 and SEG strains are under the control of multiple genes with additive effects stands in contrast with other infectious diseases in which single gene mutations with major effects were identified. In the case of Oas1b, a nonsense mutation was probably present in the very early founders of laboratory strains and became fixed in the absence of any selective pressure in the vast majority of these strains. 17 This mutation has not yet been found in inbred strains derived from progenitors of different Mus musculus subspecies. In the case of plague, the highly resistant phenotype of the SEG strain results from the accumulation of several gain-of-function genetic variations, each of which provides a moderate but significant advantage in the control of Y. pestis proliferation and systemic dissemination. The acquisition of this phenotype may have resulted from selective pressure exerted by endemic exposure to Y. pestis-hosting fleas in wild rodents.
The identification of genes controlling the resistant phenotype of SEG mice will involve the creation and characterization of congenic mouse strains carrying the three genomic regions identified in this study. This will be followed by the genetic dissection of each genomic region to prioritize positional candidates for DNA sequencing and functional evaluation using loss of function alleles at these genes. At the same time, construction and characterization of bi or tricongenic strains will aim to recapitulate the resistant phenotype observed in the M. spretus-derived SEG strain.
Materials and methods
Mice and crosses SEG was first bred as a closed colony by François Bonhomme in Montpellier, France, from M. spretus progenitors trapped in Spain, near Granada. 37 It was later established as an inbred strain and maintained since 1995 at the Institut Pasteur. C57BL/6 (B6), FVB/NCrl, BALB/cByJ and SJL/JOrlCrl mice were purchased at 6 weeks of age from Charles River Laboratory (L'Arbresle, France). They were maintained for at least 3 weeks in the Institut Pasteur animal facilities before inoculation. CAST/Ei mice were bred at the Institut Pasteur from progenitors purchased from The Jackson Laboratory (Bar Harbor, ME, USA). To produce BSB, SEG males were mated with B6 females and the resulting F1 females were mated with B6 males. All animal experiments were approved and conducted in accordance with the Institut Pasteur Biosafety Committee and in compliance with French and European regulation on protection of animals used for scientific purposes. Mice were kept in isolators after inoculation. They were given food and water ad libitum and were kept at 22±2 1C with alternating 12 h periods of light and dark.
Culture of Y. pestis strains and experimental infections of mice Experimental infections were performed using the virulent Y. pestis strains CO92 11 and 6/69. 12 Cultures were carried out at 28 1C for 48 h on Luria-Bertani agar medium supplemented with 0.2% (W/v) hemin. Bacteria were collected and suspended in saline. Bacterial concentration was estimated by spectrometry at 600 nm (1 O.D. B10
9 CFU per ml) and confirmed by CFU counts on Luria-Bertani hemin agar plates. Mice were injected subcutaneously. between 8 and 12 weeks of age, in the ventral region, with a 100 ml inoculum and were then monitored daily for 14 days.
Genotyping
Tail biopsies were collected at weaning from BSB mice and high-quality DNA was prepared by standard phenol-chloroform extraction. For BSB genotyping, 1536 single nucleotide polymorphisms were genotyped at the Centre National de Génotypage (Evry, France) using the Illumina GoldenGate platform (Illumina, Inc., San Diego, CA, USA). A total of 721 markers covering the entire mouse genome were polymorphic and gave reliable genotypes.
Statistical and QTL analysis Survival curves were compared by a logrank (MantelCox) test using StatView 5.0 (SAS Institute Inc, Cary, NC, USA). Survival rates were compared by Fisher's exact test. QTL analysis was performed by using the R/qtl software version 1.07-12 running under R 2.6.0. 39 The survival rate was analyzed as a binary trait. Significance thresholds of LOD scores were estimated by 1000 permutations of experimental data and were 2.77 and 2.43 for 5 and 10% thresholds, respectively. Ninety-five percent CI were estimated using the bayesint() function of R/qtl. QTL analysis of mortality time in susceptible BC mice was also performed with R/qtl using a nonparametric model.
